Lung Cancer:
Lung Cancer Symptoms, Treatment Options for Lung Cancer, Small Cell Lung Cancer, News Information on Lung Cancer.
-
May 25th, 2005
The addition of the monoclonal antibody Bevacizumab (Avastin) to the standard treatment for advanced, non squamous non small cell lung cancer produced improved survival rates.
-
May 21st, 2005
Surgeons can see lung disease and early signs of cancer that would otherwise be undetectable with a CAT scan, blood test or white light bronchoscopy.
-
May 20th, 2005
Study reveals complex mechanism underlying resistance to targeted lung cancer drugs.
-
May 18th, 2005
Finding a new approach that can pinpoint which proteins contribute to malignancy is critical because current approaches we use to diagnose and treat lung cancer have had no significant impact on lung cancer mortality.
-
May 2nd, 2005
Researchers have closed a randomized clinical trial comparing gefitinib (Iressa TM) vs. placebo following chemotherapy and radiation for patients with non small cell lung cancer.
-
Apr 20th, 2005
Scientists are developing a non invasive test that could detect lung cancer in its earliest stages, while it is still treatable.
-
Bevacizumab Combined with Chemotherapy Prolongs Survival for Some Patients with Advanced Lung CancerMar 15th, 2005
Results from a clinical trial for patients with previously untreated advanced non squamous, non small cell lung cancer show that those patients who received bevacizumab (Avastin) in combination with standard chemotherapy lived longer than patients who received the same chemotherapy without bevacizumab.
-
Mar 8th, 2005
Lung Cancer Patients May Benefit From Study, which helps to explain why non small cell lung cancer (NSCLC) tumors become resistant to the cancer therapy gefitinib.
